6-MTH group results (IFRS)

Nxera Pharma

13/08/2020 07:30

Aug 13 (Reuters)- 
              Sosei Group Corp 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   6 months ended      6 months ended       Year to 
                  Jun 30, 2020        Jun 30, 2019     Dec 31, 2020 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales               2.52                5.06                      
                   (-50.2 pct)        (+180.4 pct)                  
  Operating         loss 1.14            731 mln                    
  Pretax            loss 1.27            292 mln                    
  Net               loss 2.12            395 mln                    
  EPS Basic      loss 27.45 yen         5.19 yen                    
  EPS Diluted    loss 27.45 yen         5.13 yen                    
  Ann Div                                  NIL              NIL     
  -Q2 Div              NIL                 NIL                      
  -Q4 Div                                  NIL              NIL     
 
  NOTE - Sosei Group Corp. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4565.T